# Treating Drug-Resistant Childhood Schizophrenia

> **NCT00048828** · PHASE4 · COMPLETED · sponsor: **Northwell Health** · enrollment: 41 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Olanzapine
- **DRUG:** Clozapine

## Key facts

- **NCT ID:** NCT00048828
- **Lead sponsor:** Northwell Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-10
- **Primary completion:** 2006-06
- **Final completion:** 2006-06
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2013-07-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00048828

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00048828, "Treating Drug-Resistant Childhood Schizophrenia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00048828. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*